Subject demographics: comparison of low and high dose vaccination groups
| Demographics and screening results | Low dose | High dose |
| 5×107 pfu | 1×108 pfu | |
| Sex | ||
| Male | 9 (90%) | 8 (80%) |
| Female | 1 (10%) | 2 (20%) |
| Median age (range) | 35.8 (21–52) | 35.1 (27–46) |
| Continent of birth | ||
| Africa | 4 (40%) | 4 (40%) |
| Asia | 0 | 1 (10%) |
| Europe | 4 (40%) | 5 (40%) |
| North America | 1 (10%) | 0 |
| South America | 1 (10%) | 0 |
| BCG | ||
| Definite | 7 (70%) | 10 (100%) |
| Uncertain | 3 (30%) | 0 (0%) |
| Latent infection (ESAT-6/CFP-10 +) | 2 (20%) | 3 (30%) |
| Median CD4 count (range) | 570 (430–1200) | 625 (410–840) |
| Median HIV RNA load (range) | 6069 (39–41 890) | 14 805 (49–71 090) |